0
USD ▼
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Endocrine And Metabolic Disorders Drugs Market Research Reports

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
Middle East & Africa Diabetic Foot Ulcer Market Forecast to 2030 - Regional Analysis - By Ulcer Type, Treatment Type, Infection Severity, and End User - Product Thumbnail Image

Middle East & Africa Diabetic Foot Ulcer Market Forecast to 2030 - Regional Analysis - By Ulcer Type, Treatment Type, Infection Severity, and End User

  • Report
  • February 2024
  • 114 Pages
  • Africa, Middle East
From
EUR$3,450USDGBP
Asia Pacific Diabetic Foot Ulcer Market Forecast to 2030 - Regional Analysis -By Ulcer Type, Treatment Type, Infection Severity, and End User - Product Thumbnail Image

Asia Pacific Diabetic Foot Ulcer Market Forecast to 2030 - Regional Analysis -By Ulcer Type, Treatment Type, Infection Severity, and End User

  • Report
  • February 2024
  • 125 Pages
  • Asia Pacific
From
EUR$3,450USDGBP
Europe Diabetic Foot Ulcer Market Forecast to 2030 - Regional Analysis -By Ulcer Type, Treatment Type, Infection Severity, and End User - Product Thumbnail Image

Europe Diabetic Foot Ulcer Market Forecast to 2030 - Regional Analysis -By Ulcer Type, Treatment Type, Infection Severity, and End User

  • Report
  • February 2024
  • 126 Pages
  • Europe
From
EUR$3,450USDGBP
North America Diabetic Foot Ulcer Market Forecast to 2030 - Regional Analysis -By Ulcer Type, Treatment Type, Infection Severity, and End User - Product Thumbnail Image

North America Diabetic Foot Ulcer Market Forecast to 2030 - Regional Analysis -By Ulcer Type, Treatment Type, Infection Severity, and End User

  • Report
  • February 2024
  • 109 Pages
  • North America
From
EUR$3,450USDGBP
Australia & South Korea Diabetic Foot Ulcer Market Size and Forecasts 2020-2030, Country Share, Trends, and Growth Opportunity Analysis Coverage By: Ulcer Type, Treatment Type, Infection Severity, End User, and Country - Product Thumbnail Image

Australia & South Korea Diabetic Foot Ulcer Market Size and Forecasts 2020-2030, Country Share, Trends, and Growth Opportunity Analysis Coverage By: Ulcer Type, Treatment Type, Infection Severity, End User, and Country

  • Report
  • September 2023
  • 113 Pages
  • Australia, South Korea Australia, South Korea
From
EUR$3,450USDGBP
Diabetic Foot Ulcer Market Size and Forecast, Global and Regional Share, Trends, and Growth Opportunity Analysis Coverage: Ulcer Type, Treatment Type, Infection Severity, End User, and Geography - Product Thumbnail Image

Diabetic Foot Ulcer Market Size and Forecast, Global and Regional Share, Trends, and Growth Opportunity Analysis Coverage: Ulcer Type, Treatment Type, Infection Severity, End User, and Geography

  • Report
  • September 2023
  • 231 Pages
  • Global
From
EUR$4,450USDGBP
South America Insulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type - Product Thumbnail Image

South America Insulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type

  • Report
  • October 2022
  • 177 Pages
From
EUR$3,450USDGBP
North America Insulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type - Product Thumbnail Image

North America Insulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type

  • Report
  • October 2022
  • 174 Pages
  • North America
From
EUR$3,450USDGBP
Middle East & Africa Insulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type - Product Thumbnail Image

Middle East & Africa Insulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type

  • Report
  • October 2022
  • 181 Pages
  • Middle East, Africa
From
EUR$3,450USDGBP
Europe Insulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type - Product Thumbnail Image

Europe Insulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type

  • Report
  • October 2022
  • 202 Pages
  • Europe
From
EUR$3,450USDGBP
Asia-Pacific Insulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type - Product Thumbnail Image

Asia-Pacific Insulin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type

  • Report
  • October 2022
  • 205 Pages
  • Asia Pacific
From
EUR$3,450USDGBP
Insulin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type and Geography - Product Thumbnail Image

Insulin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type and Geography

  • Report
  • July 2022
  • 255 Pages
  • Global
From
EUR$4,450USDGBP
Adenosine Triphosphate Swab Test Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type and Application - Product Thumbnail Image

Adenosine Triphosphate Swab Test Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type and Application

  • Report
  • January 2021
  • Global
From
EUR$4,450USDGBP
Insulin Resistance - Epidemiology Forecast to 2032 - Product Thumbnail Image

Insulin Resistance - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Mannose Phosphate Isomerase (MPI) Deficiency - Epidemiology Forecast to 2032 - Product Thumbnail Image

Mannose Phosphate Isomerase (MPI) Deficiency - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Japan Diabetes Drugs And Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Thumbnail Image

Japan Diabetes Drugs And Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • May 2025
  • 70 Pages
  • Japan
From
EUR$4,750USDGBP
Asia-Pacific Insulin Delivery Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029 - Product Thumbnail Image

Asia-Pacific Insulin Delivery Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029

  • Report
  • February 2024
  • 90 Pages
  • Asia Pacific
From
EUR$4,750USDGBP
Australia Insulin Delivery Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Australia Insulin Delivery Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 70 Pages
  • Australia
From
EUR$4,750USDGBP
Canada Insulin Delivery Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Canada Insulin Delivery Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 75 Pages
  • Canada
From
EUR$4,750USDGBP
Europe Insulin Delivery Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Europe Insulin Delivery Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 90 Pages
  • Europe
From
EUR$4,750USDGBP
Loading Indicator

The Endocrine and Metabolic Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat endocrine and metabolic disorders. Endocrine disorders are conditions that affect the body's hormones, while metabolic disorders are conditions that affect the body's ability to process and use energy. Endocrine and metabolic disorders can include diabetes, thyroid disorders, obesity, and adrenal disorders. Endocrine and Metabolic Disorders Drugs are typically developed by pharmaceutical companies and are prescribed by physicians. These drugs can be used to treat a variety of endocrine and metabolic disorders, including diabetes, thyroid disorders, obesity, and adrenal disorders. Common drugs used to treat these conditions include insulin, metformin, and glucagon-like peptide-1 (GLP-1) agonists. Some of the major companies in the Endocrine and Metabolic Disorders Drugs market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and AstraZeneca. These companies are involved in the development, production, and marketing of drugs used to treat endocrine and metabolic disorders. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more